Ovarian Embryonal Carcinoma
NCI Definition: An embryonal carcinoma arising from the ovary. Signs and symptoms include the presence of an abdominal mass and abdominal pain. 
There are 5 clinical trials for ovarian embryonal carcinoma, of which 3 are open and 2 are completed or closed. Of the trials that contain ovarian embryonal carcinoma as an inclusion criterion, 2 are phase 1 (2 open) and 3 are phase 2 (1 open).
Aldesleukin, cyclophosphamide, and fludarabine are the most common interventions in ovarian embryonal carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.